|
FRRS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.92220025954748E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.71605002114484E-14 |
| Normal-vs-Stage2 |
1.27780000025446E-07 |
| Normal-vs-Stage3 |
1.18179910302274E-11 |
| Normal-vs-Stage4 |
7.11659620122873E-11 |
| Stage1-vs-Stage2 |
6.895400E-01 |
| Stage1-vs-Stage3 |
4.468400E-01 |
| Stage1-vs-Stage4 |
1.290050E-01 |
| Stage2-vs-Stage3 |
3.698800E-01 |
| Stage2-vs-Stage4 |
9.068000E-02 |
| Stage3-vs-Stage4 |
3.888600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.10782519111308E-15 |
| Normal-vs-AfricanAmerican |
1.180740E-04 |
| Normal-vs-Asian |
1.12900000459604E-09 |
| Caucasian-vs-AfricanAmerican |
4.929200E-01 |
| Caucasian-vs-Asian |
5.160800E-01 |
| AfricanAmerican-vs-Asian |
2.556000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.4870996635259E-11 |
| Normal-vs-Female |
9.09399999748928E-10 |
| Male-vs-Female |
1.263410E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.5833999666981E-09 |
| Normal-vs-Age(41-60Yrs) |
3.84649978535379E-10 |
| Normal-vs-Age(61-80Yrs) |
3.61830010398023E-10 |
| Normal-vs-Age(81-100Yrs) |
1.595640E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.452400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.170400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.548800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.842200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.485200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.431200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.414600E-01 |
| Classical-VS-Follicular |
3.870200E-01 |
| Classical-VS-Other |
5.029000E-01 |
| Classical-VS-Normal |
1.3926999553604E-09 |
| Tall-VS-Follicular |
1.582160E-01 |
| Tall-VS-Other |
9.536000E-01 |
| Tall-VS-Normal |
9.6332000043553E-08 |
| Follicular-VS-Other |
4.128800E-01 |
| Follicular-VS-Normal |
1.09070000031686E-07 |
| Other-VS-Normal |
2.044600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.10276240864005E-13 |
| Normal-vs-N1 |
4.69260186264364E-11 |
| N0-vs-N1 |
8.588300E-02 |
|
|
